In the CY 2026 OPPS/ASC proposed rule (90 FR 33755 through 33756), for the Hospital OQR, REHQR, and ASCQR Programs, we proposed to remove the HCHE and FCHE measures beginning with the CY 2025 reporting period/CY 2027 payment or program determination under removal Factor 8, as the costs associated with achieving a high score on the measure outweigh the benefit of its continued use in the program ( 419.46(i)(3)(i)(H), 419.95(e)(3)(i)(H), and 416.320(c)(2)(viii), respectively)
TB-500 promotes cellular recovery and helps regulate inflammation
B12 Injections and Weight Management While B12 injections are often marketed as a way to boost energy and support weight loss, its important to note that current scientific evidence does not support the use of B12 injections for weight management in individuals with normal B12 levels
Inhibition of NNMT has been explored in preclinical research for potential effects on adiposity regulation, insulin sensitivity, and metabolic efficiency